LTT Bio-Pharma and Others to Co-develop Adhesive Preparation in China.Tokyo, Japan, May 30, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - LTT LTT Lews Therin Telamon (Wheel of Time series) LTT Long-Term Training LTT Light Tactical Trailer LTT Lunar Transit Telescope LTT Limited Team Training LTT Live Training Transformation Bio-Pharma has agreed with Mikasa Seiyaku and Beijing Tide Pharmaceutical on the development and sale of adhesive preparations in China. Under the agreement terms, the three parties will jointly develop analgesic analgesic (ăn'əljē`zĭk), any of a diverse group of drugs used to relieve pain. Analgesic drugs include the nonsteroidal anti-inflammatory drugs (NSAIDs) such as the salicylates, narcotic drugs such as morphine, and synthetic drugs poultices for both ethical (prescription) and over-the-counter use by following Mikasa Seiyaku's proprietary products, Zepolas (ethical drug) and Zenol (over-the-counter drug over-the-counter drug A therapeutic agent that does not require a prescription, which the FDA feels can be safely self-prescribed by non-physicians. Cf Prescription drug, Under-the-counter. ). Going forward, Beijing Tide Pharmaceutical will conduct clinical trials in China and file a new drug application in 2007. Currently, analgesic poultices for ethical use are not distributing in China. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion